Digestive Disease & Surgery Institute Outcomes
General Surgery
General Surgery
General Surgery ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall general surgery ACS NSQIP performance benchmarked against 701 participating sites.
| General Surgery (701 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 1287 | 1.48% | 2.00% |
| 30 Day Morbidity | 1287 | 16.16% | 17.03% |
| Cardiac | 1287 | 1.09% | 1.18% |
| Pneumonia | 1287 | 2.10% | 2.09% |
| Unplanned Intubation | 1285 | 1.63% | 1.40% |
| Ventilator > 48 Hours | 1281 | 1.95% | 1.75% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 1287 | 2.87% | 2.39% |
| Renal Failureᵃ | 1284 | 3.50% | 2.42% |
| Urinary Tract Infection (UTI) | 1287 | 1.01% | 1.66% |
| Surgical Site Infection (SSI) | 1277 | 8.93% | 9.59% |
| Sepsis | 1250 | 3.44% | 3.61% |
| C.diff Colitisᵃ | 1287 | 1.55% | 0.72% |
| Unplanned Reoperation | 1287 | 4.82% | 5.21% |
| Unplanned Readmissionᵃ | 1287 | 13.44% | 11.39% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.
